ELANElanco Animal Health Incorporated
What is the market doing?
No clear lean: insiders cluster-buying, but in a downtrend (−3% vs 200-day).
In a downtrend, below its 50- and 200-day averages. Price is −3% vs its 200-day average.
Multiple insiders bought with their own money, the strongest form of the signal (the 90 days ending Oct 8, 2026).
Moderately shorted, settled Sep 15, 2026, about a week of normal trading to cover. Up 2.9% since the previous count, down from 7.0% of shares outstanding three months ago.
Against the whole market›
Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.
Where this answer is blind. Insider selling is often routine (taxes, diversification); only cluster buying is a strong tell.
How ELAN is trading
Elanco Animal Health Incorporated is +19% over the past year while the S&P 500 is +18%: 1.1 points ahead of the market.
1-year return · S&P 500 +18%
- vs 200-day average
- −2.9%
vs 200-day average · below trend, but not far
- RSI (14)
- 57
RSI (14) · neutral
- Below its 52-week high
- 15%
Below its 52-week high
Details›
- Last close2026-10-09
- $22.92
- 1 monthS&P 500 +2.7%
- +0.22%
- 1 yearS&P 500 +18%
- +19%
- 5 yearsS&P 500 +88%
- −30%
- vs 50-day average$23.44
- −2.2%
- 52-week high
- $26.84
- 52-week low
- $18.54
- Annualised volatility
- 47%
- Insider buying, net, 6 monthsForms 3/4/5 to 2026-10-08
- $1.7M
| Year | Return |
|---|---|
| 2026 (year to date) | +1.3% |
| 2025 | +87% |
| 2024 | −19% |
| 2023 | +22% |
| 2022 | −57% |
| 2021 | −7.5% |
| 2020 | +4.1% |
| 2019 | −6.6% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 8 | 3 of 8 | +0.11% |
| Feb | 8 | 5 of 8 | +1.1% |
| Mar | 8 | 2 of 8 | −7.7% |
| Apr | 8 | 3 of 8 | −2.7% |
| May | 8 | 4 of 8 | +7.7% |
| Jun | 8 | 5 of 8 | +0.12% |
| Jul | 8 | 5 of 8 | +3.4% |
| Aug | 8 | 4 of 8 | +2.0% |
| Sep | 8 | 2 of 8 | −4.2% |
| Oct | 9 | 6 of 9 | −1.5% |
| Nov | 8 | 5 of 8 | +4.9% |
| Dec | 8 | 3 of 8 | +1.3% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.
Drug Manufacturers, Specialty & Generic
Ranks #20 of 41 by RyuScore